TSE:9158Healthcare
CUC (TSE:9158) Q3 Net Margin Compression Challenges Bullish Growth Narratives
CUC (TSE:9158) has just posted its Q3 2026 scorecard, with revenue at ¥13.9b and basic EPS of ¥28.01, while trailing twelve month revenue sits at ¥52.7b and EPS at ¥61.20. The company has seen quarterly revenue move from ¥11.0b in Q2 2025 to ¥13.9b in Q3 2026, with basic EPS ranging from ¥35.58 in Q2 2025 to ¥7.10 in Q1 2026 and ¥28.01 in the latest quarter. This sets up a mixed but data rich backdrop for assessing the story. Taken together with the recent margin compression and past profit...